Cancer Research Meeting Calendar  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lorenzo, K.
Right arrow Articles by Mach, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lorenzo, K.
Right arrow Articles by Mach, L.
[Cancer Research 60, 4070-4076, August 1, 2000]
© 2000 American Association for Cancer Research


Biochemistry and Biophysics

Invasive Properties of Murine Squamous Carcinoma Cells: Secretion of Matrix-degrading Cathepsins Is Attributable to a Deficiency in the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor1

Kim Lorenzo2, Phuong Ton2, Jason L. Clark, Sogué Coulibaly3 and Lukas Mach4

Department of Biochemistry, University of Western Australia, Nedlands WA 6907, Australia [K. L., P. T., J. L. C., L. M.], and Zentrum für Angewandte Genetik, Universität für Bodenkultur Wien, A-1190 Vienna, Austria [S. C., L. M.]

Penetration of basement membrane layers is a hallmark feature of metastatic tumor cells. The invasive propensity of murine SCC-VII squamous carcinoma cells is in part attributable to the extracellular action of the lysosomal cysteine proteinase cathepsin B. Although most noncancerous cells store this enzyme in the lysosomes, we found that SCC-VII cells release a large fraction (42%) of their newly synthesized procathepsin B into the culture medium. Procathepsins D and L, the precursors of other major lysosomal proteinases, are also secreted in significant amounts (24 and 75%, respectively). In contrast, normal murine 3T3-L1 fibroblasts exocytose only minor amounts of their newly synthesized procathepsins B (10%), D (<1%), and L (16%). Western blotting analysis revealed that SCC-VII cells are deficient in the 300 kDa mannose 6-phosphate/insulin-like growth factor-II receptor (M6P/IGF2R), a tumor suppressor with a central role in the intracellular transport of lysosomal enzymes. Consistent with the absence of M6P/IGF2R, SCC-VII cells lack dense lysosomes, with the bulk of intracellular acid hydrolases residing in late endosomes/prelysosomes. On the other hand, the synthesis of the M6P recognition marker on lysosomal enzymes is not impaired in SCC-VII cells, because [33P]Pi is incorporated into the carbohydrate moieties of procathepsins B, D, and L. Furthermore, 69% of the phosphorylated N-linked oligosaccharides synthesized by SCC-VII cells carry phosphomonoester groups and as such constitute high-affinity ligands for M6P receptors. SCC-VII cells express the 46 kDa cation-dependent M6P receptor (MPR46), but intracellular retention of procathepsins B, D, and L is not affected by ammonium chloride and chloroquine, agents known to perturb the M6P receptor system. Our results indicate that failure to express the 300 kDa M6P/IGF2R may enhance the metastatic capacity of tumor cells by inducing the secretion of procathepsins B, D, and L.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
H. B. Schiller, A. Szekeres, B. R. Binder, H. Stockinger, and V. Leksa
Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor Limits Cell Invasion by Controlling {alpha}V{beta}3 Integrin Expression and Proteolytic Processing of Urokinase-type Plasminogen Activator Receptor
Mol. Biol. Cell, February 1, 2009; 20(3): 745 - 756.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Tu, C. F. Ortega-Cava, G. Chen, N. D. Fernandes, D. Cavallo-Medved, B. F. Sloane, V. Band, and H. Band
Lysosomal Cathepsin B Participates in the Podosome-Mediated Extracellular Matrix Degradation and Invasion via Secreted Lysosomes in v-Src Fibroblasts
Cancer Res., November 15, 2008; 68(22): 9147 - 9156.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. P. Rose, M. Bogyo, A. V. Moses, and K. Fruh
Insulin-Like Growth Factor II Receptor-Mediated Intracellular Retention of Cathepsin B Is Essential for Transformation of Endothelial Cells by Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., August 1, 2007; 81(15): 8050 - 8062.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. C. Probst, P. Ton, B. Svoboda, A. Gannon, W. Schuhmann, J. Wieser, R. Pohlmann, and L. Mach
The 46-kDa mannose 6-phosphate receptor does not depend on endosomal acidification for delivery of hydrolases to lysosomes
J. Cell Sci., December 1, 2006; 119(23): 4935 - 4943.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Collins, C. M. Stack, S. M. O'Neill, S. Doyle, T. Ryan, G. P. Brennan, A. Mousley, M. Stewart, A. G. Maule, J. P. Dalton, et al.
Cathepsin L1, the Major Protease Involved in Liver Fluke (Fasciola hepatica) Virulence: PROPEPTIDE CLEAVAGE SITES AND AUTOACTIVATION OF THE ZYMOGEN SECRETED FROM GASTRODERMAL CELLS
J. Biol. Chem., April 23, 2004; 279(17): 17038 - 17046.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. N. Szentirmay, H.-X. Yang, S. A. Pawar, C. Vinson, and M. Sawadogo
The IGF2 Receptor Is a USF2-specific Target in Nontumorigenic Mammary Epithelial Cells but Not in Breast Cancer Cells
J. Biol. Chem., September 26, 2003; 278(39): 37231 - 37240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.